Proud to build the Centre of Excellence for Autism Together
MicroSigX is honored to join CUHK Medicine and partners for the formation of Centre of Excellence, a visionary platform dedicated to improving the lives of children with Autism Spectrum Disorder (ASD).
As a CUHK spin-off, our role is clear to drive industry innovation through research and development and accelerate the commercialization of MSX MetaGenie, the world’s first multikingdom microbiome technology for early ASD risk detection. MSX MetaGenie is developed using proprietary technology based on a panel of multi-kingdom microbial biomarkers developed from a renowned university in Hong Kong.
This is more than technology—it’s about collaboration, shared vision, and creating a future where innovation truly benefits society. By turning breakthrough science into practical solutions, we aim to empower doctors, support families, and position Hong Kong as a global hub for neurodevelopmental innovation.
Photo Credit: Ming Pao
To learn more:
CUHK Med (Chi): https://lnkd.in/gnPTQwz2
SCMP Post (Eng) : https://lnkd.in/gz6x5-Gj
